文献速递神经MR

7T下人类脑临床高分辨率三维磁共振波谱成像

Clinical High-Resolution 3D-MR Spectroscopic Imaging of the Human Brain at 7 T.
PubMed 文献 · Invest Radiol · 2020-01-01

研究开发了用于7T的自由感应衰减磁共振波谱成像序列,采用快速同心环轨迹编码,在约3分钟至约15分钟内实现全脑代谢物成像,并在健康志愿者、多发性硬化患者和胶质瘤患者中验证了临床可行性。

要点

  • 7T FID-MRSI结合同心环轨迹编码可在约3分钟(32×32×31矩阵)至约15分钟(80×80×47矩阵)内完成全脑代谢物成像。
  • 最高分辨率矩阵下可可靠检测8种代谢物及大分子,肌醇在多发性硬化相关改变中最高增加达100%。
  • 肿瘤组织代谢图显示胆碱最高增加200%、谷氨酰胺最高增加100%及甘氨酸增加,提供优于单层MRSI的信息。

核心结论

  • 7T FID-MRSI采用快速同心环轨迹读出,可提供兼顾速度或小病灶细节及低丰度代谢物研究的临床可用采集方案,可补充多种脑部疾病的临床MR检查。
  • 在多发性硬化患者和胶质瘤患者中显示了肌醇、谷氨酰胺、总胆碱、甘氨酸和N-乙酰天冬氨酸浓度的显著代谢异常。

研究设计与样本

  • 前瞻性研究,经机构审查委员会批准并获书面知情同意。
  • 在分辨率体模中验证同心环轨迹编码,采用不同矩阵尺寸进行测量。
  • 前瞻性测量1例多发性硬化患者、1例胶质瘤患者和6名健康志愿者。
  • 矩阵尺寸范围从32×32×31(标称体素6.9×6.9×4.2 mm,采集约3分钟)到80×80×47(标称体素2.7×2.7×2.7 mm,采集约15分钟)。

关键影像表现/征象

  • 体模中直径小至3至4 mm的结构可见。
  • 在体MRSI提供高频谱质量,中位信噪比>6.3,线宽<0.082 ppm。
  • 全脑覆盖可显示多发性硬化相关神经化学改变的全范围,如肌醇最高增加达100%。
  • 三维脑肿瘤代谢图显示肿瘤组织胆碱最高增加200%、谷氨酰胺最高增加100%及甘氨酸增加。

诊断标准与关键数值

  • 80×80×47矩阵下,Cramér-Rao下界从谷氨酰胺<22%(亚皮层灰质最高CRLB)到N-乙酰天冬氨酸<9.5%(颞叶最高CRLB)。
  • 所有分辨率下可可靠映射最多8种代谢物(N-乙酰天冬氨酸、N-乙酰天冬氨酰谷氨酸、总肌酸、谷氨酰胺、谷氨酸、总胆碱、肌醇、甘氨酸)及大分子。

临床应用与阅片要点

  • 7T FID-MRSI采集方案可针对速度或小病灶细节及低丰度代谢物研究进行裁剪,补充多种脑部疾病的临床MR检查。
  • 全脑覆盖有助于显示多发性硬化相关神经化学改变的完整范围及三维肿瘤代谢分布。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Available clinical magnetic resonance spectroscopic imaging (MRSI) sequences are hampered by long scan times, low spatial resolution, strong field inhomogeneities, limited volume coverage, and low signal-to-noise ratio. High-resolution, whole-brain mapping of more metabolites than just N-acetylaspartate, choline, and creatine within clinically attractive scan times is urgently needed for clinical applications. The aim is therefore to develop a free induction decay (FID) MRSI sequence with rapid concentric ring trajectory (CRT) encoding for 7 T and demonstrate its clinical feasibility for mapping the whole cerebrum of healthy volunteers and patients.

MATERIALS AND METHODS: Institutional review board approval and written informed consent were obtained. Time-efficient, 3-dimensional encoding of an ellipsoidal k-space by in-plane CRT and through-plane phase encoding was integrated into an FID-MRSI sequence. To reduce scan times further, repetition times were shortened, and variable temporal interleaves were applied. Measurements with different matrix sizes were performed to validate the CRT encoding in a resolution phantom. One multiple sclerosis patient, 1 glioma patient, and 6 healthy volunteers were prospectively measured. For the healthy volunteers, brain segmentation was performed to quantify median metabolic ratios, Cramér-Rao lower bounds (CRLBs), signal-to-noise ratios, linewidths, and brain coverage among all measured matrix sizes ranging from a 32 × 32 × 31 matrix with 6.9 × 6.9 × 4.2 mm nominal voxel size acquired in ~3 minutes to an 80 × 80 × 47 matrix with 2.7 × 2.7 × 2.7 mm nominal voxel size in ~15 minutes for different brain regions.

RESULTS: Phantom structures with diameters down to 3 to 4 mm were visible. In vivo MRSI provided high spectral quality (median signal-to-noise ratios, >6.3 and linewidths, <0.082 ppm) and fitting quality. Cramér-Rao lower bounds were ranging from less than 22% for glutamine (highest CRLB in subcortical gray matter) to less than 9.5% for N-acetylaspartate for the 80 × 80 × 47 matrix (highest CRLB in the temporal lobe). This enabled reliable mapping of up to 8 metabolites (N-acetylaspartate, N-acetylaspartyl glutamate, total creatine, glutamine, glutamate, total choline, myo-inositol, glycine) and macromolecules for all resolutions. Coverage of the whole cerebrum allowed visualization of the full extent of diffuse and local multiple sclerosis-related neurochemical changes (eg, up to 100% increased myo-inositol). Three-dimensional brain tumor metabolic maps provided valuable information beyond that of single-slice MRSI, with up to 200% higher choline, up to 100% increased glutamine, and increased glycine in tumor tissue.

CONCLUSIONS: Seven Tesla FID-MRSI with time-efficient CRT readouts offers clinically attractive acquisition protocols tailored either for speed or for the investigation of small pathologic details and low-abundant metabolites. This can complement clinical MR studies of various brain disorders. Significant metabolic anomalies were demonstrated in a multiple sclerosis and a glioma patient for myo-inositol, glutamine, total choline, glycine, and N-acetylaspartate concentrations.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Hingerl L, Strasser B, Moser P, et al. Clinical High-Resolution 3D-MR Spectroscopic Imaging of the Human Brain at 7 T. Invest Radiol. 2020. PMID: 31855587. doi:10.1097/RLI.0000000000000626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。